1. Relationship between cellular morphology and abnormality of SWI/SNF complex subunits in pancreatic undifferentiated carcinoma

   • Takeo Yamamoto
   • Kenichi Kohashi
   • Yoshinao Oda

   Original Article – Clinical Oncology 24 November 2021 Pages: 2945 - 2957

   

2. Adjuvant chemotherapy following combined induction chemotherapy and concurrent chemoradiotherapy improves survival in N2–3-positive nasopharyngeal carcinoma patients

   • Hao-Yun Tao
   • Hui Liu
   • Rong-Hui Zheng

   Original Article – Clinical Oncology 25 November 2021 Pages: 2959 - 2969

   

3. Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort

   • Xue Qin Yu
   • David Goldsbury
   • Dianne L. O’Connell

   Original Article – Clinical Oncology 25 November 2021 Pages: 2971 - 2984

   

4. Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients

   • Ryota Nakamura
   • Tadaaki Yamada
   • Koichi Takayama

   Original Article – Clinical Oncology 26 November 2021 Pages: 2985 - 2994

   

5. Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

   • Sang-A Kim
   • Hyejoo Park
   • Keun-Wook Lee

   Original Article – Clinical Oncology 01 December 2021 Pages: 2995 - 3005

   

6. Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease

   • Holger Rumpold
   • M. Hackl
   • D. Wolf

   Original Article – Clinical Oncology 03 January 2022 Pages: 3007 - 3014

   

7. Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation

   • Sophie Scherer-Trame
   • Lina Jansen
   • Hermann Brenner

   Original Article – Clinical Oncology Open access 07 December 2021 Pages: 3015 - 3028

8. Carboplatin and nab-paclitaxel chemotherapy with or without atezolizumab as front-line management for treatment-naïve metastatic nonsquamous non-small cell lung cancer with PD-L1 staining: a retrospective study

   • Bo Xu
   • Huihui Cheng
   • Wenbo Guo

   Original Article – Clinical Oncology Open access 01 January 2022 Pages: 3029 - 3038

   

9. Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer

   • Sven H. Loosen
   • Karel Kostev
   • Christoph Roderburg

   Original Article – Clinical Oncology Open access 12 December 2021 Pages: 3039 - 3046

   

10. Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection

    • Jinhua Feng
    • Ka Li
    • Fuyu Li

    Original Article – Clinical Oncology Open access 25 January 2022 Pages: 3047 - 3059

    

11. Animal study of a newly designed metal airway brachytherapy stent loaded with radioactive ¹²⁵I seeds

    • Dechao Jiao
    • Qinyu Lei
    • Xinwei Han

    Original Article – Clinical Oncology 03 January 2022 Pages: 3061 - 3069

    

12. Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study

    • Andrea Brunner
    • Wolfgang Kruis
    • Dirk Michael Forner

    Original Article – Clinical Oncology 03 January 2022 Pages: 3071 - 3079

    

13. Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study

    • Ziyi Xu
    • Xuezhi Hao
    • Puyuan Xing

    Original Article – Clinical Oncology Open access 04 January 2022 Pages: 3081 - 3089

    

14. Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer

    • Satoshi Katayama
    • Victor M. Schuettfort
    • Shahrokh F. Shariat

    Original Article – Clinical Oncology Open access 08 January 2022 Pages: 3091 - 3102

    

15. The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy

    • L. Susok
    • S. Said
    • T. Gambichler

    Original Article – Clinical Oncology Open access 10 January 2022 Pages: 3103 - 3108

    

16. Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents

    • Carsten Nieder
    • Siv G. Aanes
    • Ellinor Haukland

    Original Article – Clinical Oncology Open access 12 January 2022 Pages: 3109 - 3116

    

17. Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany

    • Louis Jacob
    • Matthias Kalder
    • Karel Kostev

    Original Article – Clinical Oncology 18 January 2022 Pages: 3117 - 3123

18. Melanocytic nevi in sentinel lymph nodes: association with cutaneous nevi and clinical relevance in patients with cutaneous melanomas

    • Lutz Kretschmer
    • Viktor Schnabel
    • Michael P. Schön

    Original Article – Clinical Oncology Open access 20 January 2022 Pages: 3125 - 3134

    

19. Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study

    • Se Young Choi
    • Moon Soo Ha
    • Hasung Kim

    Original Article – Clinical Oncology 21 January 2022 Pages: 3135 - 3144

    

20. ACC2 is under-expressed in lung adenocarcinoma and predicts poor clinical outcomes

    • Fei-Yuan Yu
    • Qian Xu
    • Yan-Ming Xu

    Original Article – Clinical Oncology 22 January 2022 Pages: 3145 - 3162

    

21. Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinoma

    • Isabelle Mohr
    • Marie Vogeler
    • Markus Mieth

    Original Article – Clinical Oncology Open access 25 January 2022 Pages: 3163 - 3174

    

22. Indications of medical plants: what do medical students in Germany know? A cross-sectional study

    • Sören Klaus Büntzel
    • Maria-Louisa Ritschel
    • Judith Büntzel

    Original Article – Clinical Oncology Open access 29 January 2022 Pages: 3175 - 3182

23. Pan-immune-inflammation value independently predicts disease recurrence in patients with Merkel cell carcinoma

    • T. Gambichler
    • S. Said
    • J. C. Becker

    Original Article – Clinical Oncology Open access 31 January 2022 Pages: 3183 - 3189

    

24. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

    • Maximilian Fleischmann
    • Sebastian Scholl
    • Ulf Schnetzke

    Original Article – Clinical Oncology Open access 31 January 2022 Pages: 3191 - 3202

    

25. The treatment strategy and outcome for spontaneously ruptured hepatocellular carcinoma: a single-center experience in 239 patients

    • Ao Huang
    • De-Zhen Guo
    • Jian Zhou

    Original Article – Clinical Oncology 03 February 2022 Pages: 3203 - 3214

    

26. Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting

    • Hye Jin Kang
    • Yoo-Kang Kwak
    • So Jung Lee

    Research 30 August 2022 Pages: 3215 - 3223